Concepts (67)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CRISPR-Cas Systems | 1 | 2022 | 98 | 0.700 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 752 | 0.460 |
Why?
|
| Fungal Proteins | 2 | 2013 | 145 | 0.460 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2025 | 87 | 0.400 |
Why?
|
| Serine | 2 | 2025 | 102 | 0.400 |
Why?
|
| COP-Coated Vesicles | 1 | 2013 | 22 | 0.400 |
Why?
|
| Pichia | 1 | 2013 | 31 | 0.400 |
Why?
|
| Endoplasmic Reticulum | 1 | 2013 | 253 | 0.350 |
Why?
|
| Gene Expression Regulation, Fungal | 2 | 2011 | 66 | 0.340 |
Why?
|
| Candida albicans | 1 | 2011 | 32 | 0.340 |
Why?
|
| Haploinsufficiency | 1 | 2011 | 69 | 0.320 |
Why?
|
| Morphogenesis | 1 | 2011 | 204 | 0.300 |
Why?
|
| Myocytes, Cardiac | 2 | 2025 | 312 | 0.200 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2022 | 135 | 0.200 |
Why?
|
| Troponin T | 1 | 2022 | 41 | 0.180 |
Why?
|
| Myocardium | 1 | 2025 | 567 | 0.180 |
Why?
|
| Gene Editing | 1 | 2022 | 51 | 0.180 |
Why?
|
| Molecular Targeted Therapy | 1 | 2022 | 304 | 0.160 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2022 | 603 | 0.140 |
Why?
|
| Phosphoglycerate Dehydrogenase | 2 | 2025 | 8 | 0.100 |
Why?
|
| Protein Transport | 2 | 2013 | 438 | 0.100 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2013 | 55 | 0.100 |
Why?
|
| Cytosol | 1 | 2013 | 192 | 0.100 |
Why?
|
| Immunoblotting | 1 | 2013 | 273 | 0.100 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 309 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 435 | 0.090 |
Why?
|
| Cell Nucleus | 2 | 2011 | 601 | 0.090 |
Why?
|
| Hyphae | 1 | 2011 | 7 | 0.090 |
Why?
|
| Genomic Library | 1 | 2011 | 30 | 0.080 |
Why?
|
| Genes, Fungal | 1 | 2011 | 62 | 0.080 |
Why?
|
| Binding Sites | 1 | 2013 | 1126 | 0.080 |
Why?
|
| Mutagenesis, Insertional | 1 | 2011 | 103 | 0.080 |
Why?
|
| Heterozygote | 1 | 2011 | 381 | 0.080 |
Why?
|
| Protein Binding | 1 | 2013 | 1526 | 0.080 |
Why?
|
| DNA-Binding Proteins | 2 | 2011 | 1231 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 958 | 0.070 |
Why?
|
| Mutation | 2 | 2022 | 4265 | 0.060 |
Why?
|
| Transcription Factors | 2 | 2011 | 1687 | 0.060 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2008 | 297 | 0.060 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2008 | 459 | 0.060 |
Why?
|
| Genetic Therapy | 1 | 2025 | 365 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2011 | 3497 | 0.050 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2022 | 20 | 0.050 |
Why?
|
| Carbazoles | 1 | 2022 | 31 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2022 | 109 | 0.050 |
Why?
|
| Glycine | 1 | 2022 | 93 | 0.050 |
Why?
|
| Imidazoles | 1 | 2022 | 138 | 0.040 |
Why?
|
| Doxycycline | 1 | 2022 | 37 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2025 | 1581 | 0.040 |
Why?
|
| Transgenes | 1 | 2022 | 171 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2022 | 312 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2022 | 254 | 0.040 |
Why?
|
| Disease Progression | 1 | 2025 | 1529 | 0.040 |
Why?
|
| Pyridines | 1 | 2022 | 302 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2022 | 249 | 0.040 |
Why?
|
| Glucose | 1 | 2022 | 686 | 0.040 |
Why?
|
| Humans | 3 | 2022 | 93132 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2025 | 2479 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2022 | 1611 | 0.030 |
Why?
|
| Mice | 1 | 2025 | 12230 | 0.020 |
Why?
|
| Nuclear Localization Signals | 1 | 2008 | 10 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2008 | 79 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2008 | 177 | 0.020 |
Why?
|
| Sirolimus | 1 | 2008 | 176 | 0.020 |
Why?
|
| Animals | 1 | 2025 | 27973 | 0.010 |
Why?
|
| Male | 1 | 2025 | 44355 | 0.010 |
Why?
|
| Phenotype | 1 | 2008 | 2545 | 0.010 |
Why?
|